Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content

Table 3 Regression coefficients in linear regression models of factors associated with total MTA score

From: Hippocampal atrophy but not white-matter changes predicts the long-term cognitive response to cholinesterase inhibitors in Alzheimer’s disease

Model

B (95 % CI)

β

P-value

Adjusted R2

I

Total WMH score

0.202 (0.147 ~ 0.258)

0.361

<0.0005

0.128

II

Total WMH score

0.181 (0.124 ~ 0.237)

0.323

<0.0005

0.150

Baseline CDR

0.728 (0.275 ~ 1.182)

0.162

0.002

III

Total WMH score

0.186 (0.130 ~ 0.242)

0.332

<0.0005

0.173

Baseline CDR

0.822 (0.371 ~ 1.273)

0.183

<0.0005

Education (year)

0.053 (0.020 ~ 0.086)

0.160

0.001

IV

Total WMH score

0.187 (0.133 ~ 0.242)

0.334

<0.0005

0.207

Baseline CDR

0.406 (−0.028 ~ 0.894)

0.090

0.102

Education (year)

0.086 (0.051 ~ 0.122)

0.260

<0.0005

Baseline TMSE

−0.099 (−0.149 ~ −0.050)

−0.240

<0.0005

V

Total WMH score

0.197 (0.143 ~ 0.250)

0.351

<0.0005

0.203

Education (year)

0.089 (0.053 ~ 0.125)

0.268

<0.0005

Baseline TMSE

−0.117 (−0.162 ~ −0.072)

−0.282

<0.0005

  1. CDR Clinical Dementia Rating, ChEI cholinesterase inhibitor, MTA medial temporal atrophy, TMSE Taiwanese Mini-Mental State Examination, WMH white matter hyperintensity, CI confidence interval; Variables entered into stepwise linear regression analysis: age of starting ChEI, educational level, baseline TMSE, baseline CDR, and total WMH score